Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Breckenridge Pharmaceutical, Inc

02 2Breckenridge Pharmaceutical, Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FDA Audited

USA

Breckenridge Pharmaceutical

City : Boca Raton

State : FL

Country/Area : US

Zip : 33487

District : FLA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2009-04-22

Breckenridge Pharmaceutical

02

FDA Audited

USA

Breckenridge Pharmaceutical

City : Boca Raton

State : FL

Country/Area : US

Zip : 33487

District : FLA

Center : CDER

Project Area : Postmarket Surv. and Epidemiolog...

District Decision : No Action Indicated

Inspection End Date : 2009-04-22

Breckenridge Pharmaceutical

03

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : CT

Country/Area : US

Zip : 06037-2352

District : NWE

Center : CDER

Project Area : Postmarket Surv. and Epidemiolog...

District Decision : No Action Indicated

Inspection End Date : 2011-05-17

Breckenridge Pharmaceutical

04

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : CT

Country/Area : US

Zip : 06037-2352

District : NWE

Center : CDER

Project Area : Postmarket Surv. and Epidemiolog...

District Decision : No Action Indicated

Inspection End Date : 2014-09-25

Breckenridge Pharmaceutical

05

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : CT

Country/Area : US

Zip : 06037-2352

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-02-21

Breckenridge Pharmaceutical

06

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : CT

Country/Area : US

Zip : 06037-2352

District : NWE

Center : CDER

Project Area : Postmarket Surv. and Epidemiolog...

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-02-21

Breckenridge Pharmaceutical